Disarm Therapeutics
is a pharmaceutical company that develops and commercializes novel therapeutics for the treatment of neurological disorders... Read moreDisarm Therapeutics
is a pharmaceutical company that develops and commercializes novel therapeutics for the treatment of neurological disorders... Read more
News
Oct 27, 2020
Global Legal Chronicle
Disarm Therapeutics: Eli Lilly's Acquisition Of Disarm Therapeutics
Oct 21, 2020
The Business Journals: St. Louis
Disarm Therapeutics: Pharma giant Eli Lilly acquires Washington University-founded startup Disarm Therapeutics for $135M
Oct 18, 2020
HrNxt
Disarm Therapeutics: Lilly to acquire Disarm Therapeutics
Oct 16, 2020
STAT News
Disarm Therapeutics: STAT Plus: Disarm Therapeutics bought by Lilly for $135 million
Oct 16, 2020
Zacks
Disarm Therapeutics: Lilly to Acquire Private Biotech for Boosting Pain Portfolio
Oct 16, 2020
PMLiVE
Disarm Therapeutics: Lilly buys biotech firm Disarm Therapeutics for $135m
Oct 15, 2020
Investor’s Business Daily
Disarm Therapeutics: Eli Lilly Acquisition Expands Efforts To Treat Neurological Diseases
Oct 15, 2020
FinanzNachrichten
Disarm Therapeutics: Lilly To Buy Disarm Therapeutics For Upfront Payment Of $135.0 Mln
Oct 22, 2019
BioPortfolio
Disarm Therapeutics: Disarm Therapeutics Reports Preclinical Data Demonstrating Small Molecule SARM1 Inhibitors Preserve Both Axonal Structure and Function In Vitro and In Vivo
Sep 11, 2019
FinanzNachrichten
Disarm Therapeutics: Disarm Therapeutics Presents Data at ECTRIMS 2019 Supporting SARM1 as a Novel Therapeutic Target for Multiple Sclerosis
Disarm Therapeutics Competitors
1
2
3
4
5
6
7
8
9